INFLUENCE OF COMBINED ANTIHYPERTENSIVE AND ANTIDEPRESSANT THERAPY ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION, ANXIETY AND DEPRESSION
https://doi.org/10.20996/1819-6446-2008-4-3-76-82
Abstract
Aim. To assess influence of combined antihypertensive (captopril or metoprolol) and antidepressant (thianeptin or sertralin) therapy on clinical status, blood pressure (BP) and myocardial function in patients with arterial hypertension (HT) and affective disorders (AD).
Material and methods. 106 patients with HT were involved in the study. 64 patients (60,4%) had concomitant AD. All patients were divided into 3 groups. 46 patients with HT and AD were included in the 1-st group. They received metoprolol or captopril in combination with tianeptine or sertaline. The 2-nd group included 18 patients with HT and AD who received only antihypertensive therapy. The 3-rd group consisted of 42 patients with HT without AD. They also received only antihypertensive therapy.
Results. After 6 month therapy patients of the 1-st and the 3-rd groups had more significant clinical improvement and BP reduction (according to 24- hour BP monitoring) as well as more farourable structural and functional changes of left ventricular in comparison with patients of the 2-nd group.
Conclusion. In patients with HT and concomitant AD combined antihypertensive and antidepressant therapy result in favourable clinical changes, effectively reduce BP, improve left ventricular structure and function.
About the Authors
Y. A. Vasyuk
Moscow State University of Medicine and Dentistry
Russian Federation
Department of clinical functional diagnostics
Russian Federation
Department of clinical functional diagnostics
T. V. Dovzenko
Moscow State University of Medicine and Dentistry
Russian Federation
Department of clinical functional diagnostics
Russian Federation
Department of clinical functional diagnostics
E. A. Nesterova
Moscow State University of Medicine and Dentistry
Russian Federation
Department of clinical functional diagnostics
Russian Federation
Department of clinical functional diagnostics
I. A. Sadulaeva
Moscow State University of Medicine and Dentistry
Russian Federation
Department of clinical functional diagnostics
Russian Federation
Department of clinical functional diagnostics
K. V. Tarasova
Moscow State University of Medicine and Dentistry
Russian Federation
Department of clinical functional diagnostics
Russian Federation
Department of clinical functional diagnostics
References
1. Devereux R.B. Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? Circulation 1997;95(8):1983-5.
2. Simone G., Devereux R.B., Koren M.J. et al. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996;93(2):259-65.
3. Levy D., Garrison R.J., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561 – 1566.
4. Ganau A., Devereux R.B., Roman M.J. et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550–8.
5. Pearson A.P., Pasierski T., Labovits A.J. Left ventricular hypertrophy, diagnosis, prognosis, management. Am Heart J 1991;121(1 Pt 1):148– 57.
6. Messerli FH, Ventura HO, Elizardi DJ, et al. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984;77:18-22.
7. McMahon S. Blood pressure and the risk of cardiovascular disease. In: J. Swales, Editor. Textbook of Hypertension. Oxford: Blackwell; 1994. P:46-57.
8. Pfeffer M.A., Pfeffer I.M. Reversing cardiac hypertrophy in hypertension. N Engl J Med 1990;322(19):1350-6.
9. Swynghedauw B. Remodelling of the heart in response to chronic mechanical overload. Eur Heart J 1989;10:935-43.
10. Карпов Р.С., Павлюкова Е.Н., Врублевский А.В. и др. Современные методы диагностики коронарного атеросклероза. Бюлл СО РАМН 2006;2(120):105-17.
11. Барац С.С., Закроева А.Г. Диастолическая дисфункция сердца по показателям трансмитрального кровотока и потока в легочных венах: дискуссионные вопросы патогенеза, терминологии и классификации. Кардиология 1998;(5):69-76.
12. Balogun M., Dunn F. Systolic and diastolic function following regression of left ventricular hypertrophy in hypertension. J Hypertens Suppl. 1991;9(2):S51-5.
13. Глотов М.Н., Мазур Н.А. Диастолическая функция левого желудочка у больных гипертонической болезнью. Кардиология 1994;(1):89–93.
14. Laine H., Katoh C., Luotolahti M. et al. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation 1999;100:2425–30.
15. Благовидова О.Б.. Михайлов В.И., Островский А.Б., Губанов А.В. Коррекция психосоматических нарушений при гипертонической болезни. В: Актуальные проблемы психиатрии, наркологии и неврологии: Сб. научн. тр. Москва – Хабаровск, 1998; С.70–75.
16. Lasnier C., Marey C., Lapeyre G. et al. Cardiovascular tolerance to tianeptine [in French]. Presse Med 1991; 20(37):1858-63.
17. Недоступ А. В., Федорова В. И., Линевич А. Ю. и др. Тревожно- депрессивные и нейромедиаторные нарушения у больных гипертонической болезнью, влияние на них терапии ципрамилом. Тер арх 2005;(11):55–62.
18. Румянцева Г.М., Милопольская И.М., Грушков А.В. и др. Эффективность лечения препаратом Танакан больных с психоорганическим синдромом пограничного уровня, получивших в прошлом различные дозы ионизирующего облучения. Российский психи- атрический журнал 1999;(1):31–6.
19. Погосова Г.В. Психоэмоциональные расстройства при сердечно – сосудистых заболеваниях. Терапевтические аспекты. Consilium medicum 2006; 8(5):118-23.
20. Оганов Р.Г., Погосова Г.В., Шальнова С.А., Деев А.Д. Депрессивные расстройства в общемедицинской практике по данным исследования КОМПАС: взгляд кардиолога. Кардиология 2005;(8):38-44.
21. Смулевич А.Б. Депрессии в общемедицинской практике. М.: МИА; 2000.
22. Балунов О.А., Захаров Д.В., Мокшанцев П.С., и др. Лечение постинсультной депрессии в раннем восстановительном периоде: опыт применения сертралина. Клин фармакол тер 2005;14(2):90- 2.
23. Glassman A.H., O’Connor C.M., Califf R.M. et al. Sertraline treatment of major depression in patient with acute MI or unstable angina. JAMA 2002;288:701-9.
24. Андрусенко М.П., Шишенин В.С., Яковлева О.Б. Использование тианептина при лечении поздних депрессий. Журн неврол психиатр им СС Корсакова 1999;99(2): 25-30.
25. Айвазян Т.А., Зайцев В.П., Таравкова И.А. Психологические предикторы участия больных гипертонической болезнью в немедикаментозной терапии. Кардиология 1995;(1):42-4.
26. Айвазян Т.А. Психорелаксация в лечении гипертонической болезни. Кардиология 1991;(2):95-8.
27. Devereux RB., Okin P.M., Roman M.J. Pre-clinical cardiovascular disease and surrogate end–points in hypertension: does race influence target organ damage independent of blood pressure? Ethn Dis 1998;8:138-48.
28. McLenachan J.M., Dargie H.J. A review of rhythm disorders in cardiac hypertrophy. Am J Cardiol. 1990;65(14):42G-44G.
29. Scheuer J. Catecholamines in cardiac hypertrophy. Am J Cardiol 1999;83(12A):70H-74H.
30. Sica D.A. The importance of the sympathetic nervous system and systolic hypertension in patients with hypertension: benefits in treating patients with increased cardiovascular risk. Blood Press Monit 2000;5 Suppl 2:S19-25.
Review
For citations:
Vasyuk Y.A., Dovzenko T.V., Nesterova E.A., Sadulaeva I.A., Tarasova K.V. INFLUENCE OF COMBINED ANTIHYPERTENSIVE AND ANTIDEPRESSANT THERAPY ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION, ANXIETY AND DEPRESSION. Rational Pharmacotherapy in Cardiology. 2008;4(3):76-82. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-3-76-82
Views:
739
Email this article 